Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
S. Kim (Jeonju, Republic of Korea), H. Kim (Jeonju, Republic of Korea), Y. Lee (Jeonju, Republic of Korea), S. Kim (Seoul, Republic of Korea). NLRP3 inflammasome conjugates with mitochondria in LPS-induced acute lung injury. 597

Member's Comments

No comment yet.

Related content which might interest you: Tetracycline alleviates acute lung injury by inhibition of NLRP3 inflammasome Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure Year: 2019 Activation of NLRP3 inflammasome is regulated by mitochondrial ROS via PI3K-HIF-VEGF pathway in acute lung injury Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015 Andrographolide inhibits the activation of NLRP3 inflammasome in patients with COPD Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 Injury induced inflammasome activation leading to IL-1b and lung inflammation depends on IL-17 Source: Annual Congress 2010 - Stem cells and growth factors in lung injury Year: 2010 Cigarette smoke extract inhibits the NLRP3 inflammasome in human macrophages and impairs cell metabolism via NLRP3-independent activation of Caspase-1 Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms Year: 2019 Statins worse pulmonary fibrosis through enhancing NLRP3 inflammasome activation Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 The activation of NLRP3 inflammasome pathway in COPD is limited in local airways Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Effect of curcumin on LPS-induced neutrophil activation and acute lung injury Source: Annual Congress 2012 - Lung injury, respiratory muscles and mechanical ventilation Year: 2012 Hypoxia induces inflammasome activation and influx of neutrophils and T-cells in the lungs Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 A role for the inflammasome effector caspase-1 in hypoxia-induced pulmonary hypertension Source: International Congress 2017 – Experimental PH Year: 2017 Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018 Elevated expression of the NLRP3 inflammasome in neutrophilic asthma Source: Eur Respir J 2014; 43: 1067-1076 Year: 2014 Silica-induced inflammasome activation in lung epithelial cells Source: Annual Congress 2012 - Abestosis, silicosis and hypersensitivity pneumonitis Year: 2012 A role for PAR1 in lipopolysaccharide induced acute lung injury Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008 Silica-induced inflammasome activation in vitro and in rat lungs Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 The NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation Source: Eur Respir J, 55 (3) 1900119; 10.1183/13993003.00119-2019 Year: 2020 Mitochondria-targeted H2S suppresses and reverses cigarette smoke-induced inflammasome activity and lung injury in experimental COPD Source: ERS Lung Science Conference 2020 Year: 2020 CHF 6001 inhibits nuclear translocation of NF-?B in LPS-induced lung inflammation in mice Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 Amifostine reduces lipopolysaccharide-induced lung dysfunction via suppression of redox-sensitive inflammatory signaling Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Kallistatin protects against LPS-induced mouse lung injury Source: Annual Congress 2012 - The many roads to lung injury Year: 2012